Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis von Hartung, H-P, Berger, T, Bermel, RA, Brochet, B, Carroll, WM, Holmøy, T, Karabudak, R, Killestein, J, Nos, C, Patti, F, Ross, A Perrin, Vanopdenbosch, L, Vollmer, T, Buffels, R, Garas, M, Kadner, K, Manfrini, M, Wang, Q, Freedman, MS

Volltext

Single-Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study von Sundar, S., Jha, T. K., Thakur, C. P., Mishra, M., Singh, V. P., Buffels, R.

Volltext

Pharmacokinetic Study of Tenofovir Disoproxil Fumarate Combined with Rifampin in Healthy Volunteers von DROSTE, J. A. H, VERWEIJ-VAN WISSEN, C. P. W. G. M, KEARNEY, B. P, BUFFELS, R, VANHORSSEN, P. J, HEKSTER, Y. A, BURGER, D. M

Volltext

Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study von Sundar, S, Jha, TK, Thakur, CP, Mishra, M, Singh, VR, Buffels, R

Volltext

P34 Ocrelizumab treatment satisfaction in patients with suboptimal response to previous disease-modifying therapies von Van Wijmeersch, B., Buffels, R., Clinch, S., Eggebrecht, J., Kuhelj, R., Wei, W., Vermersch, P.

Volltext

Pregnancy outcomes in patients treated with ocrelizumab von Oreja-Guevara, C., Wray, S., Buffels, R., Zecevic, D., Vukusic, S.

Volltext

Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I-II study von FASSAS, A, BUFFELS, R, ANAGNOSTOPOULOS, A, GACOS, E, VADIKOLIA, C, HALOUDIS, P, KALOYANNIDIS, P

Volltext

Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with a suboptimal response to previous disease-modifying therapies (1‑year interim result... von Vermersch, P., Eralinna, J.P., Nicholas, R., Oreja-Guevara, C., Siva, A., Van Wijmeersch, B., Wiendl, H., Buffels, R., Kuhelj, R., Wei, W., Comi, G.

Volltext

Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I–II study von Fassas, A., Buffels, R., Anagnostopoulos, A., Gacos, E., Vadikolia, C., Haloudis, P., Kaloyannidis, P.

Volltext

Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis von Hartung, H.-P, Berger, T, Bermel, R.A, Brochet, B, Carroll, W.M, Holmøy, T, Karabudak, R, Killestein, J, Nos, C, Patti, F, Ross, A. Perrin, Vanopdenbosch, L, Vollmer, T, Buffels, R, Garas, M, Kadner, K, Manfrini, M, Wang, Q, Freedman, M.S

Volltext

Ensemble-plus Study Design: An Investigation of Shortened Ocrelizumab Infusion Time on Infusion-related Reactions in Patients with Relapsing Multiple Sclerosis from the Phase Iiib... von Yamout, B., Brochet, B., Nos, C., Freedman, M.S., Killstein, J., Overell, J., Buffels, R., Fitovski, K., Mehta, L., Wang, Q., Hartung, H.

Volltext

Shorter infusion time of ocrelizumab: Results from the randomized, doubleblind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis von Hartung, HP, Berger, T, Bermel, RA, Brochet, B, Carroll, WM, Holmøy, Trygve, Karabudak, R, Killestein, J, Nos, C, Patti, Francesco, Ross, A, Vanopdenbosch, L, Vollmer, Timothy, Buffels, R, Garas, M, Kadner, Kathrin, Manfrini, M, Wang, Q, Freedman, M

Volltext

Safety of high‐dose liposomal daunorubicin (daunoxome) for refractory or relapsed acute myeloblastic leukaemia von Fassas, Athanasios, Buffels, Regine, Kaloyannidis, Panayotis, Anagnostopoulos, Achilles

Volltext

Assessment of progression of COPD: report of a workshop held in Leuven, 11–12 March 2004 von Decramer, M, Gosselink, R, Rutten-Van Mölken, M, Buffels, J, Van Schayck, O, Gevenois, P-A, Pellegrino, R, Derom, E, De Backer, W

Volltext

Treating allergic rhinitis: continuous versus on-demand regime? Executive summary of the Supportive Initiatives for the Global Management of Allergy (SIGMA): report from the Belgia... von Church, M K, Watelet, J B

Volltext